Literature DB >> 21768295

A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells.

Kathryn W Juchem1, Britt E Anderson, Cuiling Zhang, Jennifer M McNiff, Anthony J Demetris, Donna L Farber, Andrew J Caton, Warren D Shlomchik, Mark J Shlomchik.   

Abstract

Effector memory T cells (T(EM)) do not cause graft-versus-host disease (GVHD), though why this is has not been elucidated. To compare the fates of alloreactive naive (T(N)) or memory (T(M)) T cells, we developed a model of GVHD in which donor T cells express a transgene-encoded TCR specific for an antigenic peptide that is ubiquitously expressed in the recipient. Small numbers of naive TCR transgenic (Tg) T cells induced a robust syndrome of GVHD in transplanted recipients. We then used an established method to convert TCR Tg cells to T(M) and tested these for GVHD induction. This allowed us to control for the potentially different frequencies of alloreactive T cells among T(N) and T(M), and to track fates of alloreactive T cells after transplantation. T(EM) caused minimal, transient GVHD whereas central memory T cells (T(CM)) caused potent GVHD. Surprisingly, T(EM) were not inert: they, engrafted, homed to target tissues, and proliferated extensively, but they produced less IFN-γ and their expansion in target tissues was limited at later time points, and local proliferation was reduced. Thus, cell-intrinsic properties independent of repertoire explain the impairment of T(EM), which can initiate but cannot sustain expansion and tissue damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768295      PMCID: PMC3234673          DOI: 10.1182/blood-2011-01-330035

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  56 in total

1.  A direct estimate of the human alphabeta T cell receptor diversity.

Authors:  T P Arstila; A Casrouge; V Baron; J Even; J Kanellopoulos; P Kourilsky
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells.

Authors:  M Ahmadzadeh; S F Hussain; D L Farber
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

3.  CD4(+) T cell effectors can become memory cells with high efficiency and without further division.

Authors:  H Hu; G Huston; D Duso; N Lepak; E Roman; S L Swain
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.

Authors:  Modesta P Ndejembi; John R Teijaro; Deepa S Patke; Adam W Bingaman; Meena R Chandok; Agnes Azimzadeh; Steven G Nadler; Donna L Farber
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 5.  Generation of gut-homing T cells and their localization to the small intestinal mucosa.

Authors:  Bengt Johansson-Lindbom; William W Agace
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

6.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

Review 7.  Graft-versus-host disease.

Authors:  Warren D Shlomchik
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 8.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

9.  Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.

Authors:  Britt E Anderson; Patricia A Taylor; Jennifer M McNiff; Dhanpat Jain; Anthony J Demetris; Angela Panoskaltsis-Mortari; Ann Ager; Bruce R Blazar; Warren D Shlomchik; Mark J Shlomchik
Journal:  Blood       Date:  2008-02-19       Impact factor: 22.113

10.  Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo.

Authors:  Matthew J O'Shaughnessy; Zong-Ming Chen; Irene Gramaglia; Patricia A Taylor; Angela Panoskaltsis-Mortari; Christine Vogtenhuber; Ed Palmer; Thomas Grader-Beck; Vassiliki A Boussiotis; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2007-05       Impact factor: 5.742

View more
  19 in total

1.  Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.

Authors:  Tomomi Toubai; Isao Tawara; Yaping Sun; Chen Liu; Evelyn Nieves; Rebecca Evers; Thea Friedman; Robert Korngold; Pavan Reddy
Journal:  Blood       Date:  2011-11-18       Impact factor: 22.113

2.  Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads.

Authors:  S Verfuerth; P S E Sousa; L Beloki; M Murray; M D Peters; A T O'Neill; S Mackinnon; M W Lowdell; R Chakraverty; E R Samuel
Journal:  Bone Marrow Transplant       Date:  2015-06-15       Impact factor: 5.483

Review 3.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

4.  IL-12 Blocks Tfh Cell Differentiation during Salmonella Infection, thereby Contributing to Germinal Center Suppression.

Authors:  Rebecca A Elsner; Mark J Shlomchik
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.423

5.  Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease.

Authors:  Motoko Koyama; Rachel D Kuns; Stuart D Olver; Neil C Raffelt; Yana A Wilson; Alistair L J Don; Katie E Lineburg; Melody Cheong; Renee J Robb; Kate A Markey; Antiopi Varelias; Bernard Malissen; Günter J Hämmerling; Andrew D Clouston; Christian R Engwerda; Purnima Bhat; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Nat Med       Date:  2011-11-29       Impact factor: 53.440

6.  PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.

Authors:  Kathryn W Juchem; Faruk Sacirbegovic; Cuiling Zhang; Arlene H Sharpe; Kerry Russell; Jennifer M McNiff; Anthony J Demetris; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

7.  MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Authors:  Nina C Zitzer; Katiri Snyder; Xiamoei Meng; Patricia A Taylor; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Ramiro Garzon; Parvathi Ranganathan
Journal:  J Immunol       Date:  2018-05-02       Impact factor: 5.422

8.  Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.

Authors:  Stacey L Fanning; Jenny Zilberberg; Johann Stein; Kristin Vazzana; Stephanie A Berger; Robert Korngold; Thea M Friedman
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

9.  Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.

Authors:  Marie Bleakley; Shelly Heimfeld; Keith R Loeb; Lori A Jones; Colette Chaney; Stuart Seropian; Ted A Gooley; Franziska Sommermeyer; Stanley R Riddell; Warren D Shlomchik
Journal:  J Clin Invest       Date:  2015-06-08       Impact factor: 14.808

10.  Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.

Authors:  Kazuhiro Mochizuki; Lijun Meng; Izumi Mochizuki; Qing Tong; Shan He; Yongnian Liu; Janaki Purushe; Henry Fung; M Raza Zaidi; Yanyun Zhang; Ran Reshef; Bruce R Blazar; Hideo Yagita; Shin Mineishi; Yi Zhang
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.